Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:PGNY NASDAQ:SBC NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$104.96-1.7%$111.90$88.96▼$136.72$1.96B0.8127,007 shs199,141 shsPGNYProgyny$22.49-4.3%$22.11$13.39▼$27.15$2.02B1.321.01 million shs1.21 million shsSBCSBC Medical Group$4.18-3.5%$4.73$2.62▼$19.50$448.64M1.27117,076 shs29,572 shsWGSGeneDx$101.60-0.3%$80.02$25.32▼$117.75$2.91B2.01967,633 shs835,293 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.70%-4.08%-4.90%-0.04%-13.51%PGNYProgyny-4.34%-2.68%+5.89%-3.19%-20.25%SBCSBC Medical Group-3.46%-12.18%-6.49%+33.42%+417,999,900.00%WGSGeneDx-0.34%+27.27%+13.15%+51.12%+210.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9388 of 5 stars3.63.00.05.04.02.53.1PGNYProgyny2.0349 of 5 stars2.31.00.00.03.62.51.3SBCSBC Medical GroupN/AN/AN/AN/AN/AN/AN/AN/AWGSGeneDx2.841 of 5 stars1.44.00.00.02.65.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5735.83% UpsidePGNYProgyny 2.67Moderate Buy$24.8210.35% UpsideSBCSBC Medical Group 0.00N/AN/AN/AWGSGeneDx 2.75Moderate Buy$100.38-1.21% DownsideCurrent Analyst Ratings BreakdownLatest SBC, WGS, ADUS, and PGNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/17/2025PGNYProgynyTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$24.00 ➝ $27.007/16/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.007/8/2025PGNYProgynyLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/8/2025PGNYProgynyLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$28.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.67$5.30 per share19.81$53.52 per share1.96PGNYProgyny$1.17B1.65$0.33 per share68.13$4.96 per share4.53SBCSBC Medical Group$205.42M2.11$0.59 per share7.14$1.90 per share2.20WGSGeneDx$362.32M8.00$1.02 per share99.63$9.71 per share10.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4323.6919.581.516.52%9.23%6.96%8/4/2025 (Estimated)PGNYProgyny$54.34M$0.5739.4634.602.364.33%10.90%7.20%8/7/2025 (Estimated)SBCSBC Medical Group$46.61MN/A0.000.74N/AN/A26.72%19.60%8/13/2025 (Estimated)WGSGeneDx-$52.29M$0.052,032.0048.61N/A0.39%16.51%9.35%N/ALatest SBC, WGS, ADUS, and PGNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025SBCSBC Medical Group$0.14N/AN/AN/A$44.71 millionN/A8/7/2025Q2 2025PGNYProgyny$0.42N/AN/AN/A$315.70 millionN/A8/4/2025Q2 2025ADUSAddus HomeCare$1.45N/AN/AN/A$345.71 millionN/A7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 million5/15/2025Q1 2025SBCSBC Medical Group$0.11$0.21+$0.10$0.21$51.52 million$47.33 million5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ASBCSBC Medical GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74PGNYProgynyN/A2.392.39SBCSBC Medical Group0.034.444.40WGSGeneDx0.192.873.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%PGNYProgyny94.93%SBCSBC Medical Group60.82%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%PGNYProgyny9.40%SBCSBC Medical Group89.47%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionablePGNYProgyny31085.72 million77.66 millionOptionableSBCSBC Medical GroupN/A103.61 million10.91 millionN/AWGSGeneDx1,20028.53 million20.09 millionOptionableSBC, WGS, ADUS, and PGNY HeadlinesRecent News About These Companies15,317 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Universal Beteiligungs und Servicegesellschaft mbH4 hours ago | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockAugust 2 at 2:07 AM | americanbankingnews.comKevin Feeley Sells 388 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockAugust 1 at 6:32 PM | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $226,837.74 in StockAugust 1 at 6:08 PM | marketbeat.comVictory Capital Management Inc. Purchases 12,945 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)August 1 at 6:54 AM | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $40,860.28 in StockAugust 1 at 6:26 AM | insidertrades.comGeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End GrowthJuly 31 at 3:48 PM | seekingalpha.comGeneDx Target of Unusually Large Options Trading (NASDAQ:WGS)July 31 at 10:59 AM | marketbeat.comWells Fargo & Company Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock PriceJuly 31 at 10:41 AM | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law GroupJuly 31 at 3:30 AM | prnewswire.comWhy GeneDx Holdings Stock Crushed It Again TodayJuly 30 at 8:48 PM | fool.comGeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law FirmJuly 30 at 5:07 PM | globenewswire.comGeneDx (NASDAQ:WGS) Shares Gap Up Following Strong EarningsJuly 30 at 10:29 AM | marketbeat.comGeneDx (NASDAQ:WGS) Announces Quarterly Earnings ResultsJuly 30 at 9:18 AM | marketbeat.comGeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more optionsJuly 30 at 9:06 AM | youtube.comYEarnings To Watch: GeneDx Holdings Corp (WGS) Reports Q2 2025 ResultJuly 30 at 4:37 AM | finance.yahoo.comGeneDx (NASDAQ:WGS) Shares Gap Up on Strong EarningsJuly 30 at 2:15 AM | americanbankingnews.comWhy GeneDx Holdings Stock Blasted 8% Higher TodayJuly 29, 2025 | fool.comGENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the FirmJuly 29, 2025 | globenewswire.comGeneDx (NASDAQ:WGS) Stock Price Up 5.4% - Still a Buy?July 29, 2025 | marketbeat.comGeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Broadcom Stock: HSBC Sets $400 Target on AI Growth PotentialBy Leo Miller | July 11, 2025View Broadcom Stock: HSBC Sets $400 Target on AI Growth PotentialSBC, WGS, ADUS, and PGNY Company DescriptionsAddus HomeCare NASDAQ:ADUS$104.96 -1.82 (-1.70%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$105.01 +0.05 (+0.05%) As of 08/1/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Progyny NASDAQ:PGNY$22.49 -1.02 (-4.34%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$22.24 -0.25 (-1.11%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.SBC Medical Group NASDAQ:SBC$4.18 -0.15 (-3.46%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.19 +0.01 (+0.22%) As of 08/1/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.GeneDx NASDAQ:WGS$101.60 -0.35 (-0.34%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$100.17 -1.43 (-1.41%) As of 08/1/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
